(Nasdaq: MGX), a precision genetic medicines company committed to developing curative therapeutics for patients using its proprietary gene editing toolbox, today provided updates on the successful ...

CRISPR screening libraries are collections of carefully designed single-guide RNAs (sgRNAs) that allow researchers to ...

Our writer thinks these two speculative shares offer high long-term growth potential from where they currently sit in the ...

New facility to support advancements in molecular diagnostics, rare disease research, and industrial microbiology ...

But, no matter what direction the general market takes, some stocks could stand out, potentially in 2025, and most ...

Leg-spinner Yuzvendra Chahal's maiden six-wicket for India as the hosts beat England by 75 runs in the third and final Twenty20 International ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

"We’re in very different place," the CEO of Editas says, citing the CRISPR pioneer's plans to get its first treatments into ...

Colossal, a leading biosciences company working to combat environmental dangers and revive extinct species, has reached a new ...

Researchers at the Broad Institute of MIT and Harvard have developed a gene-editing treatment for prion disease that extends lifespan by about 50 percent in a mouse model of the fatal ...

CRISPR-Cas systems are prokaryotic immune systems ... like particles optimized to safely and efficiently introduce this technology into human cells of therapeutic interest. Genetic control of ...